Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

Summary

The objective of this study is to evaluate the immunogenicity and safety of GSK Biologicals' investigational vaccine GSK2340272A.

Timeline

Start

2009-09-14

Primary completion

2010-04-30

Completion

2010-04-30

Publications

• Background Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P. Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial. BMC Infect Dis. 2012 Jul 23;12:162. doi: 10.1186/1471-2334-12-162.

Drugs

Indications